Evidence map›Paper›PMID 23084747›Full record

ArticleCell reports2012

An in vivo functional screen uncovers miR-150-mediated regulation of hematopoietic injury response.

Brian D Adams, Shangqin Guo, Haitao Bai, Yanwen Guo, Cynthia M Megyola, Jijun Cheng, Kartoosh Heydari, Changchun Xiao, E Premkumar Reddy, Jun Lu

Abstract read
In one paragraph

Article in Cell reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in aging · 2021
    Review
  8. Frontiers in immunology · 2020
    Article
  9. Syngeneic red blood cell-induced extracellular vesicles suppress delayed-type hypersensitivity to self-antigens in mice.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Blood · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Brian D AdamsDepartment of Genetics, Yale Stem Cell Center, Yale Cancer Center and Yale Center for RNA Science and Medicine, Yale University, New Haven, CT 06520, USA.
Shangqin Guo
Haitao Bai
Yanwen Guo
Cynthia M Megyola
Jijun Cheng
Kartoosh Heydari
Changchun Xiao
E Premkumar Reddy
Jun Lu

Funding

RED BLOOD CELL DISEASES, HEMOSTASIS, AND BLOOD BANKINGT32HL007262 · NHLBI · YALE UNIVERSITY · PI DHODAPKAR, MADHAV V · 1985 to 2011
$4.0M
The role of microRNAs in leukemic initiation and maintenanceR01CA149109 · NCI · YALE UNIVERSITY · PI LU, JUN · 2011 to 2015
$1.7M
MicroRNA Regulation of Stem Cell Self-renewalK01DK082982 · NIDDK · YALE UNIVERSITY · PI GUO, SHANGQIN · 2009 to 2013
$748k
NCI NIH HHS 1R01CA149109NCI NIH HHS R01 CA149109NHLBI NIH HHS 5T32HL007262-34NHLBI NIH HHS T32 HL007262NIDDK NIH HHS 5K01DK082982NIDDK NIH HHS K01 DK082982
6 · The paper itself

Abstract

Hematopoietic stem and progenitor cells are often undesired targets of chemotherapies, leading to hematopoietic suppression requiring careful clinical management. Whether microRNAs control hematopoietic injury response is largely unknown. We report an in vivo gain-of-function screen and the identification of miR-150 as an inhibitor of hematopoietic recovery upon 5-fluorouracil-induced injury. Utilizing a bone marrow transplant model with a barcoded microRNA library, we screened for barcode abundance in peripheral blood of recipient mice before and after 5-fluorouracil treatment. Overexpression of screen-candidate miR-150 resulted in significantly slowed recovery rates across major blood lineages, with associated impairment of bone marrow clonogenic potential. Conversely, platelets and myeloid cells from miR-150 null marrow recovered faster after 5-fluorouracil treatment. Heterozygous knockout of c-myb, a conserved target of miR-150, partially phenocopied miR-150-forced expression. Our data highlight the role of microRNAs in controlling hematopoietic injury response and demonstrate the power of in vivo functional screens for studying microRNAs in normal tissue physiology.

Indexed as

AnimalsBlood CellsBone Marrow CellsBone Marrow TransplantationCell LineageCells, CulturedFluorouracilGene Expression ProfilingGene LibraryHematopoiesisHeterozygoteMiceMicroRNAsProto-Oncogene Proteins c-mybRadiation, IonizingFluorouracilMicroRNAsMirn150 microRNA, mouseProto-Oncogene Proteins c-myb

Identifiers

PMID23084747
PMCPMC3487471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.